share

2,4(1H,3H)-Quinazolinedione,3-[[(3-Bromo-6,7,8,9-Tetrahydro-2-Hydroxy-1-Dibenzofuranyl)Methylene]Amino]-(9Ci) CAS NO 579444-27-2


Unit Price:

CAS No.:579444-27-2

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

2,4(1H,3H)-Quinazolinedione,3-[[(3-Bromo-6,7,8,9-Tetrahydro-2-Hydroxy-1-Dibenzofuranyl)Methylene]Amino]-(9Ci) is a high-purity, structurally complex heterocyclic compound designed for advanced research and development. This specialized chemical serves as a critical building block or intermediate in the synthesis of novel pharmacologically active molecules. It is primarily needed by pharmaceutical R&D laboratories and fine chemical manufacturers focused on developing new therapeutic agents.

Application

  • Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates targeting central nervous system (CNS) disorders, oncology, or inflammation.
  • Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies to explore and optimize biological activity profiles.
  • Organic Synthesis Building Block: Employed in the construction of complex fused heterocyclic systems due to its quinazolinedione and dibenzofuran scaffolds.
  • Biochemical Tool Compound: Potential use in biochemical assays to study enzyme inhibition or receptor binding mechanisms.
  • High-Value Fine Chemical Production: Serves as an intermediate in the multi-step synthesis of specialty chemicals for advanced applications.

Basic Information

Product Name 2,4(1H,3H)-Quinazolinedione,3-[[(3-Bromo-6,7,8,9-Tetrahydro-2-Hydroxy-1-Dibenzofuranyl)Methylene]Amino]-(9Ci)
CAS No. 579444-27-2
Molecular Formula C21H16BrN3O4
Molecular Weight 454.28 g/mol
Synonyms 3-[[(3-Bromo-6,7,8,9-tetrahydro-2-hydroxy-1-dibenzofuranyl)methylene]amino]-2,4(1H,3H)-quinazolinedione; 3-[(3-Bromo-2-hydroxy-6,7,8,9-tetrahydrodibenzo[b,d]furan-1-yl)methylene]amino]quinazoline-2,4(1H,3H)-dione; 579444-27-2; (9CI) Quinazolinedione derivative; Bromo-tetrahydro-dibenzofuranyl-quinazolinedione.
EINECS Contact for details

Quality Control

Our 2,4(1H,3H)-Quinazolinedione derivative is manufactured under strict quality protocols. Each batch undergoes rigorous analytical testing including HPLC for purity, NMR and IR for structural confirmation, and residual solvent analysis to ensure compliance with ICH guidelines. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with every shipment to guarantee reproducible performance in your synthetic processes.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). This compound may be light-sensitive and/or moisture-sensitive; prolonged exposure to light, heat, or humidity should be avoided to maintain stability and purity.

Specification

Item Specification
Appearance Off-white to light yellow powder
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference
Purity (HPLC) ≥ 97.0%
Water Content (KF) ≤ 0.5%
Residual Solvents (GC) Complies with ICH Q3C
Heavy Metals ≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.